Peptide PEGylation Service

Services & Products




Get published in Nature

LifeTein Referral Rewards Program

Peptide PEGylation Service

peptide synthesis Quote

LifeTein's customized PEGylation offerings and services adeptly enhance the therapeutic potential of peptides and small molecules. This chemical process, known as PEGylation, involves the strategic attachment of polyethylene glycol (PEG) chains to molecules of interest, thereby optimizing their pharmacokinetic profiles.

Enhancements from PEGylation include augmented molecular weight and an invisible cloak against proteases, leading to prolonged bioactivity and presence in systemic circulation. Such alterations amplify solubility and biocompatibility and dial down immunogenic responses, advancing the molecule's physical and chemical robustness. LifeTein's prowess in this technique is a boon for the burgeoning field of biopharmaceutical delivery.

With LifeTein, your peptides or small entities transform into PEGylated forms, complete with comprehensive analysis documentation, ready for further application at your facility. Embracing a global scope, LifeTein can fulfill demands for high-grade functionalized PEGs crucial for your PEGylated therapeutic proteins, and clickable lipids.

PEGylation service platform is extensive:

  • Versatile reactive PEG linker options including amine-reactive PEG acid and aminooxy PEG, click chemistry facilitators like alkyne PEG, and thiol-reactive PEG Maleimide
  • Preliminary PEGylation feasibility assessments
  • Developmental phases for PEG-drug conjugates, from pilot production to process evolution
  • Crafting PEGylated biosimilars for established biologics

PEGylation's therapeutic boons are noteworthy:

  • Sharpened solubility and enzyme resistance, where the hydrophilic PEG chain fosters a protective hydration layer around the drug molecule, shielding it from enzymatic breakdown and reducing immunogenicity.
  • Infrequent dosing requirements with potential toxicity mitigation, thanks to PEG's minimal toxicity profile, biodegradability, and elimination mechanisms tailored to molecular size.
  • Stabilized drug profiles with elongated half-lives in circulation, deriving from PEG's non-immunogenic nature and lack of antibody induction when conjugated with proteins.

LifeTein's prowess extends to the precise attachment of PEGs to a spectrum of molecular entities, as delineated below:

  • Monofunctional PEG Maleimide with varying molecular weights for single-point attachment
  • Bifunctional Maleimide PEG Maleimide, enabling dual attachment points
  • Lipid-conjugated PEGs like DSPE-PEG-MAL for targeted drug delivery systems
  • Specialty PEGs like Biotin PEG Maleimide and FITC PEG Maleimide for diagnostic and therapeutic purposes
  • Multi-arm PEG Maleimides for creating branched molecular architectures

Through innovative spacer utilization, such as Fmoc-ε-Ahx-OH, LifeTein enhances peptide chain flexibility, supporting efficient synthesis and fluorescent labeling processes. This adaptability translates to improved synthesis yields and peptide stability, reinforcing the utility of LifeTein’s PEGylation services in advancing medical science.

Traceless Protein Enter Cells Cell Penetrating Peptides

Poly(2-ethyl-2-oxazoline) Conjugation Service

LifeTein is at the forefront of pioneering materials science, currently promoting a groundbreaking material known as Poly(2-ethyl-2-oxazoline), or PEOz. This innovative polymer is poised to revolutionize the biomedical and pharmaceutical fields, offering a superior alternative to the widely used Polyethylene Glycol (PEG). LifeTein's advancement in this area is a testament to the ongoing evolution in drug delivery systems, showcasing PEOz's superior stability, enhanced functionality, and sensitivity to pH changes.

PEG, despite its extensive application in biomedicine for improving protein solubility and immunogenicity, exhibits limitations such as low dispersion, limited biocompatibility, and susceptibility to oxidative degradation. Furthermore, the presence of anti-PEG antibodies in patients underscores the need for alternatives. LifeTein's exploration of PEOz emerges as a timely solution, addressing these challenges with its high stability, tunability, and excellent biocompatibility.

PEOz distinguishes itself by offering higher stability and tunability compared to PEG, enabling the development of sophisticated polymeric architectures. This versatility facilitates the creation of novel drug delivery systems, such as micelles and nanoparticles, designed for targeted therapy and sustained drug release. The pH sensitivity of PEOz, due to tertiary amide groups that interact with hydrogen ions, enables responsive drug release mechanisms, particularly beneficial in acidic tumor environments or specific intracellular compartments.

In the realm of biomedical applications, PEOz's utility extends beyond traditional drug delivery. Its structural similarity to natural peptides ensures minimal immune system recognition, paving the way for its use in biosensing, tissue engineering, and as excipients in drug formulations. The development of PEOz-based hydrogels, micelles, and conjugates demonstrates its potential to enhance therapeutic efficacy and patient compliance.

LifeTein's dedication to expanding the reach and application of PEOz is evident in their comprehensive product offerings. From block copolymers to PEOz-functionalized lipids and various derivatives, LifeTein ensures that researchers and pharmaceutical companies have access to a wide range of PEOz-based materials. These offerings are not limited to traditional applications but also include innovative solutions like amphiphilic copolymers for drug carriers and biodegradable constructs for tissue regeneration.

As the biomedical field evolves, the shift towards polymers like PEOz represents a significant advancement in our ability to meet the complex challenges of modern medicine. LifeTein's contribution to this evolution highlights the potential of PEOz to set new standards in drug delivery and biomedical applications, promising improved patient outcomes and the opening of new avenues in precision medicine.

By harnessing the unique properties of PEOz, LifeTein is not just contributing to the material science landscape but is also shaping the future of therapeutic interventions and regenerative medicine. The ongoing research and development of PEOz-based materials signify a pivotal moment in biomedical engineering, heralding a new era of innovative, effective, and patient-friendly medical solutions.

Please click here to get a peptide synthesis service quote now!

                        peptide synthesis Quote